Improving Behavioral Health Outcomes with Medication Intelligence

Learn how Magellan Health saved $1500-$4300 per member per year

Join Caroline Carney, MD, MSc, FAMP, CPHQ and Amy Mosher-Garvey, MBA, LCSW as they share how Magellan Health and Arine collaborated to save $1500 to $4300 per member per year in behavioral health spend. Together, they will explore the approach they used to pinpoint outliers in behavioral health prescribing patterns. This targeted approach to medication optimization reduced polypharmacy by 45% to 55% and improved member adherence to their behavioral health medications by 20%.

What you'll learn

In this comprehensive presentation, you'll learn
  • The challenges facing behavioral health prescribers
  • The costs of inappropriate prescribing and drug-related problems for health plan members and the US healthcare system
  • The approach Magellan Health and Arine took to achieve improved outcomes, helping members live their healthiest lives
Register today for an on-demand session or a scheduled session to learn how to start reducing polypharmacy, improving adherence, and achieving cost savings.


Caroline Carney, MD, MSc, FAMP, CPHQ
Chief Medical Officer
Magellan Health
Dr. Caroline Carney is a board-certified internist and a board-certified psychiatrist. She joined Magellan Health in 2016 and serves as Magellan Health’s President of Behavioral Health and Chief Medical Officer. Her previous experience includes the role of SVP Chief Medical Officer of Magellan Behavioral Health and Magellan Specialty Health. She served as the chief medical officer for regional health plans where she gained experience in Medicaid, Medicare, Exchange, and commercial populations.
Amy Mosher-Garvey, MBA, LCSW
Vice President of Client Success
As the VP of Client Success at Arine, Amy Mosher-Garvey empowers health plans and providers to augment their medication management with medication intelligence. Amy also founded and co-owns a Madison, Wisconsin-based outpatient behavioral health clinic that provides mental health and substance use services to individuals and families. Her work in behavioral health informs her approach to improving cost, quality, and outcomes at the plan and provider level because she sees firsthand how a system built for sick care, not healthcare, impacts patients’ day-to-day lives.

Reducing costs and improving outcomes for members with behavioral health conditions.

Reducing cost of care for behavioral health conditions has proven uniquely challenging. Annual costs are 3.4x higher for individuals with a behavioral health condition, such as anxiety, depression, or a substance abuse disorder, than costs for people without those conditions. While prescribers and health plans alike understand the scope of the problem, resolving it is difficult. Prescribers have limited visibility into medications their patients are taking and lack the data to pinpoint and prevent medication-related problems. As a result, patients with behavioral health conditions experience high levels of polypharmacy, improper drug selection, non-adherence, and more costly drug-related problems.

This webinar provides an in-depth look at how Arine and Magellan Health took a two-pronged approach, combining AI-driven medication intelligence and targeted provider outreach to solve drug-related problems for members with behavioral health conditions. The result? Together, Magellan Health was able to leverage 360-degree views of each patient to connect the dots, resolve barriers to care, and address prescribing patterns at the provider level.

This program has the prescriber in mind. . . . It makes patient care much less complex. If you think about the myriad of medications a primary care provider might have to take care of for medical issues, as well as behavioral health issues, this provides the right support and helps simplify the process for those prescribers.
Caroline Carney, MD, MSc, FAMP, CPHQ